Market Research Logo

ViroPharma Incorporated (VPHM) - Financial and Strategic SWOT Analysis Review

44 Pages GlobalData September 24, 2013 SKU: GBDT5124756

ViroPharma Incorporated (VPHM)

Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

ViroPharma Incorporated (ViroPharma) is a biopharmaceutical company. It develops and commercializes products for the treatment of various serious life threatening ailments. The company’s marketed products include Cinryze, for the treatment of Hereditary Angioedema (HAE); Vancocin, for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus; Buccolam, for the treatment of Pediatric Epilepsy; and Plenadren for treatment of adrenal insufficiency in adults. The product pipeline of Viropharma comprises Cinryze (C1 esterase inhibitor [human]) for management of HEA; VP 20621 for the management of C.

ViroPharma Incorporated Key Recent Developments

Sep 09, 2013: ViroPharma To Participate In The Stifel Nicolaus 2013 Healthcare Conference
Aug 01, 2013: ViroPharma Announces Second Quarter 2013 Financial Results
Jul 25, 2013: ViroPharma To Release 2013 Second Quarter Financial Results On August 1, 2013
Jul 01, 2013: ViroPharma to Participate in the JMP Securities 2013 Healthcare Conference
May 01, 2013: ViroPharma Reports Revenue Of $107.1m In Q1 2013

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Show Full Description

Show Table of Contents

ViroPharma Incorporated (VPHM) - Financial and Strategic SWOT Analysis Revi...

September 24, 2013

Search inside this report

Pricing & Delivery

Online Download
Site License
Global Site License

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.

CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download CTA

Share this report